A Double-Blind Crossover Study in Healthy Volunteers to Compare Two Formulations of Proellex for Oral Administration

Trial Profile

A Double-Blind Crossover Study in Healthy Volunteers to Compare Two Formulations of Proellex for Oral Administration

Completed
Phase of Trial: Phase I

Latest Information Update: 05 Sep 2014

At a glance

  • Drugs Telapristone (Primary)
  • Indications Breast cancer; Endometriosis; Uterine leiomyoma
  • Focus Adverse reactions; Pharmacokinetics
  • Sponsors Repros Therapeutics
  • Most Recent Events

    • 02 Sep 2014 Status changed from recruiting to completed, as per ClinicalTrials.gov record.
    • 21 May 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top